Cargando…

Antithrombotic Agents for tPA‐Induced Cerebral Hemorrhage: A Systematic Review and Meta‐Analysis of Preclinical Studies

BACKGROUND: tPA (tissue‐type plasminogen activator) remains the only approved drug for acute ischemic stroke, with a potentially serious adverse effect: hemorrhagic transformation. The effects of antithrombotic agents on tPA‐induced hemorrhagic transformation after ischemic stroke are not clearly de...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yang, Zhang, Fu‐Tao, Wang, Xiao‐Yi, Tong, Hong‐Xuan, Zhu, Yu‐Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955384/
https://www.ncbi.nlm.nih.gov/pubmed/33283576
http://dx.doi.org/10.1161/JAHA.120.017876
_version_ 1783664240153853952
author Ye, Yang
Zhang, Fu‐Tao
Wang, Xiao‐Yi
Tong, Hong‐Xuan
Zhu, Yu‐Tian
author_facet Ye, Yang
Zhang, Fu‐Tao
Wang, Xiao‐Yi
Tong, Hong‐Xuan
Zhu, Yu‐Tian
author_sort Ye, Yang
collection PubMed
description BACKGROUND: tPA (tissue‐type plasminogen activator) remains the only approved drug for acute ischemic stroke, with a potentially serious adverse effect: hemorrhagic transformation. The effects of antithrombotic agents on tPA‐induced hemorrhagic transformation after ischemic stroke are not clearly defined. We performed a systematic review and meta‐analysis in preclinical studies aiming to evaluate the efficacy of antithrombotic agents on tPA‐induced hemorrhagic transformation after ischemic stroke. METHODS AND RESULTS: We conducted a systematic review and meta‐analysis of studies testing antithrombotic agents in animal models of tPA‐induced hemorrhagic transformation. The pooled effects were calculated using random‐effects models, and heterogeneity was explored through meta‐regression and subgroup analyses. Publication bias was assessed using trim and fill method and the Egger test. The efficacy of 18 distinct interventions was described in 22 publications. The pooled data showed a significant improvement in cerebral hemorrhage, infarct size, and neurobehavioral outcome in treated compared with control animals (standardized mean difference, 0.45 [95% CI, 0.11–0.78]; standardized mean difference, 1.18 [95% CI, 0.73–1.64]; and standardized mean difference, 0.91 [95% CI, 0.49–1.32], respectively). Subgroup analysis indicated that quality score, random allocation, control of temperature, anesthetic used, stroke model used, route of drug delivery, time of drug administration, and time of assessment were significant factors that influenced the effects of interventions. CONCLUSIONS: Administration with antiplatelet agents revealed statistically significant improvement in all the outcomes. Anticoagulant agents showed significant effects in infarct size and neurobehavioral score, but fibrinolytic agents did not show any significant improvement in all the outcomes. The conclusions should be interpreted cautiously given the heterogeneity and publication bias identified in this analysis.
format Online
Article
Text
id pubmed-7955384
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79553842021-03-17 Antithrombotic Agents for tPA‐Induced Cerebral Hemorrhage: A Systematic Review and Meta‐Analysis of Preclinical Studies Ye, Yang Zhang, Fu‐Tao Wang, Xiao‐Yi Tong, Hong‐Xuan Zhu, Yu‐Tian J Am Heart Assoc Systematic Review and Meta‐analysis BACKGROUND: tPA (tissue‐type plasminogen activator) remains the only approved drug for acute ischemic stroke, with a potentially serious adverse effect: hemorrhagic transformation. The effects of antithrombotic agents on tPA‐induced hemorrhagic transformation after ischemic stroke are not clearly defined. We performed a systematic review and meta‐analysis in preclinical studies aiming to evaluate the efficacy of antithrombotic agents on tPA‐induced hemorrhagic transformation after ischemic stroke. METHODS AND RESULTS: We conducted a systematic review and meta‐analysis of studies testing antithrombotic agents in animal models of tPA‐induced hemorrhagic transformation. The pooled effects were calculated using random‐effects models, and heterogeneity was explored through meta‐regression and subgroup analyses. Publication bias was assessed using trim and fill method and the Egger test. The efficacy of 18 distinct interventions was described in 22 publications. The pooled data showed a significant improvement in cerebral hemorrhage, infarct size, and neurobehavioral outcome in treated compared with control animals (standardized mean difference, 0.45 [95% CI, 0.11–0.78]; standardized mean difference, 1.18 [95% CI, 0.73–1.64]; and standardized mean difference, 0.91 [95% CI, 0.49–1.32], respectively). Subgroup analysis indicated that quality score, random allocation, control of temperature, anesthetic used, stroke model used, route of drug delivery, time of drug administration, and time of assessment were significant factors that influenced the effects of interventions. CONCLUSIONS: Administration with antiplatelet agents revealed statistically significant improvement in all the outcomes. Anticoagulant agents showed significant effects in infarct size and neurobehavioral score, but fibrinolytic agents did not show any significant improvement in all the outcomes. The conclusions should be interpreted cautiously given the heterogeneity and publication bias identified in this analysis. John Wiley and Sons Inc. 2020-12-05 /pmc/articles/PMC7955384/ /pubmed/33283576 http://dx.doi.org/10.1161/JAHA.120.017876 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Systematic Review and Meta‐analysis
Ye, Yang
Zhang, Fu‐Tao
Wang, Xiao‐Yi
Tong, Hong‐Xuan
Zhu, Yu‐Tian
Antithrombotic Agents for tPA‐Induced Cerebral Hemorrhage: A Systematic Review and Meta‐Analysis of Preclinical Studies
title Antithrombotic Agents for tPA‐Induced Cerebral Hemorrhage: A Systematic Review and Meta‐Analysis of Preclinical Studies
title_full Antithrombotic Agents for tPA‐Induced Cerebral Hemorrhage: A Systematic Review and Meta‐Analysis of Preclinical Studies
title_fullStr Antithrombotic Agents for tPA‐Induced Cerebral Hemorrhage: A Systematic Review and Meta‐Analysis of Preclinical Studies
title_full_unstemmed Antithrombotic Agents for tPA‐Induced Cerebral Hemorrhage: A Systematic Review and Meta‐Analysis of Preclinical Studies
title_short Antithrombotic Agents for tPA‐Induced Cerebral Hemorrhage: A Systematic Review and Meta‐Analysis of Preclinical Studies
title_sort antithrombotic agents for tpa‐induced cerebral hemorrhage: a systematic review and meta‐analysis of preclinical studies
topic Systematic Review and Meta‐analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955384/
https://www.ncbi.nlm.nih.gov/pubmed/33283576
http://dx.doi.org/10.1161/JAHA.120.017876
work_keys_str_mv AT yeyang antithromboticagentsfortpainducedcerebralhemorrhageasystematicreviewandmetaanalysisofpreclinicalstudies
AT zhangfutao antithromboticagentsfortpainducedcerebralhemorrhageasystematicreviewandmetaanalysisofpreclinicalstudies
AT wangxiaoyi antithromboticagentsfortpainducedcerebralhemorrhageasystematicreviewandmetaanalysisofpreclinicalstudies
AT tonghongxuan antithromboticagentsfortpainducedcerebralhemorrhageasystematicreviewandmetaanalysisofpreclinicalstudies
AT zhuyutian antithromboticagentsfortpainducedcerebralhemorrhageasystematicreviewandmetaanalysisofpreclinicalstudies